Machine learning identifies moth-receptor agonists that attract larvae
Random-forest and k-nearest-neighbors QSAR models trained on known odorant responses prioritized natural-product candidates for two Spodoptera littoralis odorant receptors. The paper reports receptor responses for selected compounds and Y-maze preference for seven strong agonists; all seven were preferred at 10⁻² dilution, while three retained preference at 10⁻³. The percentages of receptor-active candidates apply to selected test sets and are not field trap accuracy. The fly-neuron assay is heterologous, and larval choice is laboratory evidence, not crop-protection efficacy or ecological safety. This extends the same group’s 2020 receptor-ligand study; count the 2021 behavior result as one study, not each molecule or a separate model discovery.
Technology: Random-forest QSAR and k-nearest-neighbors classifier
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Selected ML-prioritized receptor ligands were tested electrophysiologically and in larval Y-maze assays; the paper reports the stated dose-dependent preference outcomes.
- Still unknown: No field efficacy, human health benefit, broad ecological selectivity or global priority is established. The study extends earlier same-group work; its compounds and behavior result are bounded to the reported assays.
- AI role: The models ranked candidate natural-product ligands for SlitOR24/SlitOR25; researchers selected the targets and candidates and performed the receptor and larval behavioral experiments.
Evidence sources: https://link.springer.com/article/10.1007/s00018-021-03919-2
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary publisher article, article metadata and author-affiliation block reviewed; summary is limited to reported assay results..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.